{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:45:54Z","timestamp":1789501554795,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.annder.2011.01.012","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T04:56:30Z","timestamp":1298436990000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pemphigo\u00efde cicatricielle\u00a0: revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"138","author":[{"given":"C.","family":"B\u00e9dane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Doffoel Hantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2011.01.012_bib0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0190-9622(91)70159-Y","article-title":"Cicatricial pemphigoid","volume":"24","author":"Ahmed","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0010","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.136.4.1231","article-title":"Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting","volume":"136","author":"Labib","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.annder.2011.01.012_bib0015","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/1523-1747.ep12876206","article-title":"Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis","volume":"94","author":"Bernard","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1523-1747.ep12329728","article-title":"Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180\u00a0extracellular domain","volume":"106","author":"Balding","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/1523-1747.ep12292701","article-title":"Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180\u00a0ectodomain: evidence that BP180\u00a0spans the lamina lucida","volume":"108","author":"Bedane","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0030","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/1523-1747.ep12323431","article-title":"Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5","volume":"105","author":"Kirtschig","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0035","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1523-1747.ep12292578","article-title":"Laminin-6\u00a0and laminin-5\u00a0are recognized by autoantibodies in a subset of cicatricial pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0040","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2008.02.035","article-title":"IgG anti-laminin-332\u00a0autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid","volume":"58","author":"Lazarova","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archderm.135.2.173","article-title":"Anti-epiligrin cicatricial pemphigoid with antibodies against the gamma2\u00a0subunit of laminin 5","volume":"135","author":"Nousari","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/1523-1747.ep12366078","article-title":"Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid","volume":"101","author":"Smith","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/1523-1747.ep12298424","article-title":"Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid","volume":"107","author":"Ghohestani","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"issue":"Suppl. 1","key":"10.1016\/j.annder.2011.01.012_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000246943","article-title":"High frequency of HLA-DQB1*0301\u00a0allele in patients with pure ocular cicatricial pemphigoid","volume":"189","author":"Chan","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2011.01.012_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1523-1747.ep12332352","article-title":"Significantly increased occurrence of HLA-DQB1*0301\u00a0allele in patients with ocular cicatricial pemphigoid","volume":"108","author":"Chan","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","article-title":"Epitope spreading: lessons from autoimmune skin diseases","volume":"110","author":"Chan","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0080","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2\u00a0in patients and healthy controls","volume":"102","author":"Budinger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2011.01.012_bib0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0738-081X(87)90046-0","article-title":"Ocular pemphigoid","volume":"5","author":"Mondino","year":"1987","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004397-199703720-00006","article-title":"Ocular cicatricial pemphigoid and ocular manifestations of pemphigus vulgaris","volume":"37","author":"Smith","year":"1997","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.annder.2011.01.012_bib0095","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ophtha.2005.01.039","article-title":"Evaluation of mucous membrane pemphigoid with ocular involvement in young patients","volume":"112","author":"Rauz","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.annder.2011.01.012_bib0100","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.annder.2011.01.012_bib0105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/000348948809700511","article-title":"Upper aerodigestive tract manifestations of cicatricial pemphigoid","volume":"97","author":"Hanson","year":"1988","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.annder.2011.01.012_bib0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.1971.04000230009002","article-title":"Benign mucous membrane pemphigoid","volume":"104","author":"Hardy","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-4362.1986.tb04544.x","article-title":"Cicatricial pemphigoid","volume":"25","author":"Ahmed","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0120","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.md.0000076003.64510.00","article-title":"Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations","volume":"82","author":"Egan","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2011.01.012_bib0125","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/clim.2001.5091","article-title":"IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5\u00a0alpha-subunit","volume":"101","author":"Lazarova","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.annder.2011.01.012_bib0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1988.tb01776.x","article-title":"Immunofluorescent studies in ocular cicatricial pemphigoid","volume":"118","author":"Leonard","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0923-1811(97)00067-4","article-title":"Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50\u00a0patients with cicatricial pemphigoid","volume":"17","author":"Murakami","year":"1998","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.annder.2011.01.012_bib0140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1523-1747.1999.00501.x","article-title":"IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180","volume":"112","author":"Nie","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0145","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.76.6.332","article-title":"Dapsone therapy for the acute inflammatory phase of ocular pemphigoid","volume":"76","author":"Fern","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.annder.2011.01.012_bib0150","first-page":"41","article-title":"The management of intransigent desquamative gingivitis with Dapsone","volume":"48","author":"Matthews","year":"1989","journal-title":"Ann Dent"},{"key":"10.1016\/j.annder.2011.01.012_bib0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1079-2104(99)70110-1","article-title":"A retrospective study of the management of oral mucous membrane pemphigoid with dapsone","volume":"88","author":"Ciarrocca","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.annder.2011.01.012_bib0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0190-9622(82)70014-3","article-title":"Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone","volume":"6","author":"Rogers","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0165","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bjo.80.6.549","article-title":"Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid","volume":"80","author":"Elder","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.annder.2011.01.012_bib0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2133.2000.03600.x","article-title":"An open clinical trial of sulphamethoxypyridazine in the treatment of mucous membrane pemphigoid","volume":"143","author":"Thornhill","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0180","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.1995.tb00727.x","article-title":"Minimizing cicatricial pemphigoid orodynia with minocycline","volume":"132","author":"Poskitt","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0185","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2230.1998.00379.x","article-title":"Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: further support for its efficacy","volume":"23","author":"Reiche","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003226-199105000-00001","article-title":"Systemic chemotherapy for ocular cicatricial pemphigoid","volume":"10","author":"Tauber","year":"1991","journal-title":"Cornea"},{"key":"10.1016\/j.annder.2011.01.012_bib0195","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2133.1999.03054.x","article-title":"Successful treatment of recalcitrant cicatricial pemphigoid with a combination of plasma exchange and cyclophosphamide","volume":"141","author":"Bohn","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0200","first-page":"101","article-title":"Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide","volume":"137","author":"Musette","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0205","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mjd.2001.114746","article-title":"Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent","volume":"45","author":"Megahed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0151-9638(05)79188-2","article-title":"Pemphigo\u00efde cicatricielle\u00a0: traitement par mycoph\u00e9nolate mof\u00e9til","volume":"132","author":"Ingen-Housz-Oro","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.012_bib0215","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2008-1034985","article-title":"Mycophenolatemofetil in ocular immunological disorders. A survey of the literature with 3\u00a0case reports","volume":"213","author":"Reis","year":"1998","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.annder.2011.01.012_bib0220","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0161-6420(99)90496-7","article-title":"Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study","volume":"106","author":"Foster","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.annder.2011.01.012_bib0225","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0230","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2003.11.012","article-title":"Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up","volume":"111","author":"Sami","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.annder.2011.01.012_bib0235","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1076\/0271-3683(200008)2121-VFT646","article-title":"Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4\u00a0antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study","volume":"21","author":"Letko","year":"2000","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.annder.2011.01.012_bib0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1067\/mjd.2001.119100","article-title":"Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept","volume":"46","author":"Sacher","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0245","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archderm.142.11.1457","article-title":"Successful treatment of mucous membrane pemphigoid with etanercept in 3\u00a0patients","volume":"142","author":"Canizares","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2340\/00015555-0132","article-title":"Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept","volume":"87","author":"Prey","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2011.01.012_bib0255","first-page":"11","article-title":"Increased serum IL-6, TNF-alpha and IL-10\u00a0levels in patients with bullous pemphigoid: relationships with disease activity","volume":"12","author":"D\u2019Auria","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.012_bib0260","first-page":"A238","article-title":"\u00c9valuation de l\u2019efficacit\u00e9 de l\u2019etanercept dans le traitement de la pemphigo\u00efde cicatricielle oculaire","volume":"135","author":"Doffoel-Hantz","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.012_bib0265","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2230.2006.02151.x","article-title":"Rituximab in refractory autoimmune bullous diseases","volume":"31","author":"Schmidt","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2011.01.012_bib0270","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12016-007-8021-6","article-title":"Rituximab in treatment-resistant autoimmune blistering skin disorders","volume":"34","author":"Schmidt","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.annder.2011.01.012_bib0275","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ophtha.2009.09.049","article-title":"Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report","volume":"117","author":"Foster","year":"2010","journal-title":"Ophthalmology."},{"key":"10.1016\/j.annder.2011.01.012_bib0280","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/bjo.80.10.927","article-title":"Local interferon alfa-2b for ocular cicatricial pemphigoid","volume":"80","author":"Gillies","year":"1996","journal-title":"Br J Ophthalmol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963811000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963811000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:58:38Z","timestamp":1758970718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963811000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0151963811000408"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2011.01.012","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemphigo\u00efde cicatricielle\u00a0: revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2011.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}